DE
38
5
NEM
57
-3
NTRS
30
3
ICE
53
-2
IFF
47
5
DVN
46
2
GD
63
4
UPS
48
2
DIS
68
2
IP
36
6
KLAC
67
4
EMC
66
4
EL
52
2
EXC
64
3
LEG
36
5
MAT
49
3
AXP
78
3
SWKS
59
7
BEN
48
-4
CINF
48
5
DE
38
5
NEM
57
-3
NTRS
30
3
ICE
53
-2
IFF
47
5
DVN
46
2
GD
63
4
UPS
48
2
DIS
68
2
IP
36
6
KLAC
67
4
EMC
66
4
EL
52
2
EXC
64
3
LEG
36
5
MAT
49
3
AXP
78
3
SWKS
59
7
BEN
48
-4
CINF
48
5
Financhill
Back

WAVE Life Sciences Quote, Financials, Valuation and Earnings

Stock Market Legend Shares Biggest Prediction Ever:

Click Here to See
Sell
37

WVE
WAVE Life Sciences

Last Price:
4.81
Seasonality Move:
2.79%

7 Day Trial

ALL ACCESS PASS

$ 7

DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon

Discover our top DeFi pick for potentially massive gains now (before it's too late).

WAVE Life Sciences Price Quote

$4.81
-0.04 (-0.82%)
(Updated: April 30, 2024 at 12:20 PM ET)

WAVE Life Sciences Key Stats

Sell
37
WAVE Life Sciences (WVE) is a Sell
Day range:
$4.70 - $4.93
52-week range:
$3.15 - $7.67
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.55
P/B ratio:
14.97%
Volume:
497.5K
Avg. volume:
609.3K
1-year change:
21.55%
Market cap:
$593.1M
Revenue:
$113.3M
EPS:
$-0.55

How Much Does WAVE Life Sciences Make?

Is WAVE Life Sciences Growing As A Company?

  • What Is WAVE Life Sciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 22.45%
  • What Is WAVE Life Sciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

WAVE Life Sciences Stock Price Performance

  • Did WAVE Life Sciences Stock Go Up Last Month?
    WAVE Life Sciences share price went down by -21.39% last month
  • Did WVE's Share Price Rise Over The Last Year?
    WVE share price rose by 21.55% over the past 1 year

What Is WAVE Life Sciences 52-Week High & Low?

WAVE Life Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy WAVE Life Sciences?

Is WAVE Life Sciences Cash Flow Positive?

  • What Is WVE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$19.4M
  • What Is WAVE Life Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $132.5M
  • What Is WAVE Life Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.1M

WAVE Life Sciences Return On Invested Capital

Data Unavailable

WAVE Life Sciences Earnings Date & Stock Price

WAVE Life Sciences Competitors

  • Who Are WAVE Life Sciences's Competitors?
    Below is a list of companies who compete with WAVE Life Sciences or are related in some way:
    • ASLAN Pharmaceuticals Ltd (ASLN)
    • EUDA Health Holdings Ltd (EUDA)
    • CytoMed Therapeutics Ltd (GDTC)
    • Haw Par Corp Ltd (HAWPF)
    • Mobile-health Network Solutions (MNDR)

WAVE Life Sciences Dividend Yield

Data Unavailable

WAVE Life Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 45.65%
Revenue: 2245.12% 46.56%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 13.00
Upside from Last Price: 168.04%

Major Shareholders

  • How many WVE shares are owned by institutional investors?
    122.5M WVE shares are owned by institutional investors
  • How many WVE shares are owned by insiders?
    958.2K WVE shares are owned by insiders